CLEVELAND, May 13, 2013 /PRNewswire/
-- DATATRAK International, Inc. (OTCQX: DTRK), a
leader in developing cloud-based, unified eClinical® technologies
and delivering related services for the clinical trials industry,
today announced a new partnership with Argentinian CRO STAT
Research. STAT Research provides a full range of research services
in the Latin American region.
(Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO
)
STAT Research CEO Dr. Conrado J.
Estol stated: "In the context of a rapidly expanding
clinical trial field in the early 2000's, we saw the opportunity to
develop a company to become leaders based on our previous research
expertise developed over many years in the USA. Our initial focus on CNS soon spanned
into many other medical specialties and our group grew solid by
incorporating some of the people with most clinical trial
experience in the region. Our recent partnership with
DATATRAK will add the necessary tools to achieve
much more effective and efficient results in an increasingly
complex and time-sensitive research environment".
"Our partnership with STAT Research combines the
DATATRAK ONE™ technology with local industry experts
to create a superior solution for advancing clinical trials in
Latin America," stated
Laurence P. Birch,
DATATRAK's Chairman of the Board and CEO. "We look
forward to assisting STAT Research in leveraging the
DATATRAK ONE™ clinical research platform to reduce
clinical trial costs and accelerate drug development
timelines."
The DATATRAK Connect™ Partner Program is
collaboration between synergic companies to accelerate the drug
development process. The program allows for extended service
offerings to cover all areas of the drug development process with
the goal of reducing study costs and furthering business
development objectives.
Join DATATRAK Thought Leaders:
LinkedIn
SlideShare
The DATATRAK Blog
Facebook
Tweet: DATATRAK Expands Latin American Presence
with New CRO Partner STAT Research http://ow.ly/kNOlA
About STAT Research
STAT Research is a medically-driven Contract Research
Organization dedicated to providing support services to
healthcare institutions, biotechnology and pharmaceutical
industries. Founded by an experienced clinical investigator, STAT
Research has the capability and expertise to conduct every step of
the clinical trial process with the highest quality and efficiency.
Operational flexibility, integrity and network are key factors to
proactively manage our clients' expectations, guaranteeing
successful results through implementation of customized solutions.
For more information on STAT Research, see
http://www.stat-research.com.
About DATATRAK
DATATRAK International is a worldwide technology and
services company delivering unified eClinical® solutions and
related services for the clinical trials industry.
DATATRAK built its multi-component, comprehensive
solution on a single, unified platform and expanded this concept to
include services delivery via DATATRAK's Clinical and
Consulting Services™ group. The Company delivers a complete
portfolio of software products designed to accelerate the reporting
of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely
integrated technologies. The DATATRAK ONE™ software
solution, deployed worldwide through an ASP or Enterprise Transfer
offering, supports Phase I – Phase IV drug and device studies in
multiple languages throughout the world. DATATRAK has
offices located in Cleveland,
Ohio; Bryan, Texas; and
Cary (RTP), North Carolina. For
more information, visit http://www.datatrak.net.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements are made based on
management's expectations, assumptions, estimates and current
beliefs concerning the operations, future results and prospects of
the Company and are subject to uncertainties and factors which are
difficult to predict and, in many instances, are beyond the control
of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking
statements. For a list of certain factors that may cause actual
results to differ materially from those contemplated in these
forward looking statements, please see the Company's report filed
with the OTCQX Market on March 15,
2013 announcing its results for the fourth quarter and full
year of 2012. The Company undertakes no obligation to update
publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.